Vaccine Testing Center, University of Vermont Trials

Vaccine Testing Center, University of Vermont	Welcome, Profile Billing Logout

Vaccine Testing Center, University of Vermont

Welcome, Profile Billing Logout

1 Trial

2 Trials

Active Trials Industry lead sponsorIndustry collaborator

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Lutton, Patricia

NCT05048875: An Evaluation of Repeated Oral Doses of JNJ-64281802 Against DENV-3 Challenge

Recruiting

JNJ-64281802 (sentinel high dose), JNJ-64281802 (remaining high dose), JNJ-64281802 (medium/low dose), JNJ-64281802 (daily dosing regimen X), JNJ-64281802 (weekly dosing regimen Y1), JNJ-64281802 (weekly dosing regimen Z2), Placebo

National Institute of Allergy and Infectious Diseases (NIAID), Janssen, LP, National Institutes of Health (NIH)

Dengue

05/23

08/24

AV1-PPD-0006, NCT06799741: A Study to Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) Infection

Recruiting

AV-1 100 mg, AV-1 300 mg, AV-1 900 mg, Placebo

AbViro LLC

DENV-3 Controlled Human Infection Model

10/25

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites